Malaysia

Sinovac’s Covid-19 vaccine safe, effective and halal: Pharmaniaga

Firm in charge of bottling, supplying Chinese made jabs confident of its effectiveness

Updated 5 years ago · Published on 02 Feb 2021 9:40PM

Sinovac’s Covid-19 vaccine safe, effective and halal: Pharmaniaga
Pharmaniaga says clinical trials of the Sinovac Covid-19 vaccine found no serious side effects from the jabs made by the Chinese pharmaceuticals company. – AFP/Twitter pic, January 3, 2021

SHAH ALAM – Pharmaniaga Bhd (Pharmaniaga) says that the CoronaVac Covid-19 vaccine by Chinese pharmaceuticals, Sinovac, is safe, effective and halal.

Pharmaniaga research and development division head, Dr Badarulhisam Abdul Rahman, said vaccines produced using inactive virus technology was the most effective and proven method of the last 40 years.

“The same method is also used for the production of vaccines for dangerous diseases such as Polio and Hepatitis A. 

“This technology has proven to be effective compared to other new technologies whose risks are not yet known,” he said when presenting the development of the vaccine virtually, today.

Also participating in the presentation session was Pharmaniaga Group managing director, Datuk Zulkarnain Md Eusope.

However, Dr Badarulhisam said confusion about the effectiveness of the vaccine arose after clinical studies in Turkey and Brazil had a score of 91.25% and 50.38%.

He explained that the study in Turkey can be seen as the benchmark, because it was tested on the general population involving 13,000 individuals aged 18 and above.

Dr Badarulhisam added that for comparison, Brazil tested said vaccine on 13,060 health workers, who were exposed to the Covid-19 virus daily.

“However, the study in Turkey will only be completed early this month. But we believe that the level of effectiveness will exceed 90%, which is above the 50% standard set by the World Health Organisation (WHO) for a vaccine to be registered,” he said.

Dr Badarulhisam added that serious side effects – including vaccine-enhanced disease – were not found in clinical studies after participants took their pair of jabs, and the majority only experienced mild reactions.

In the meantime, Zulkarnain said Pharmaniaga had researched the contents, formulas and methods  the vaccine was produced and was confident that it was halal to use as stated by the Indonesian Ulema Council.

He also expects the Sinovac vaccine to be approved by the National Pharmaceutical Regulatory Division (NPRA) by the end of this month or early March before being distributed in April.

“According to the agreement, Pharmaniaga will supply 12 million doses of this vaccine. In the first month, we will supply one million doses of the vaccine followed by two million doses in the next month to be distributed by the government,” he said.

Asked whether Pharmaniaga might sell the vaccine to the private sector, especially to industries for the use of their foreign workers, Zulkarnain said the matter was being discussed with the government.

“We are currently in talks with the government because after supplying 12 million doses of the vaccine, Pharmaniaga will still have a supply of another two million doses. 

“However, the government has requested that the vaccine be given to government-linked companies (GLCs) which are ‘economic fronliners’ as well as foreign workers and expatriates.

“Pharmaniaga is also gathering information about it and once completed, we will negotiate how it will be carried out. However, the distribution of vaccines for Malaysians is our priority at this time,” he said.

On January 12, Pharmaniaga signed an agreement with Sinovac to supply 14 million doses of the Covid-19 vaccine, the bottling process of which was done at a high-tech factory in Puchong, Selangor.

Two weeks later, Pharmaniaga signed an agreement to supply 12 million doses of CoronaVac Covid-19 vaccine to the Health Ministry. – Bernama, February 2, 2021

Related News

Malaysia / 5mth

Covid-19 cases in Malaysia stable, no deaths recorded this year – MOH

Malaysia / 8mth

Bad move to channel EPF dividends into Account 3 for festive withdrawals, cautions economist

Opinion / 1y

A tale of two administrations: How Warisan and GRS shaped Sabah’s future

Malaysia / 1y

MOH closely monitoring Covid-19 amid rising cases in neighbouring countries

Opinion / 1y

The Trump dilemma and reclaiming balance: The urgent need for fair global trade

Culture & Lifestyle / 1y

Renowned public health expert honoured at award ceremony in Penang

Spotlight

Malaysia

Khalid urges PAS to ditch Umno alliance and support Anwar

By Alfian Z.M. Tahir

Malaysia

Najib’s house arrest: Govt, AG, Hannah opposed conditional pardon, minutes show

Malaysia

Former Negeri Sembilan exco members end legal fight over removal

Business

Nvidia rules out Jensen Huang comeback as quarterly revenue doubles to US$115b

Malaysia

Indonesia should compensate Malaysians for the prolonged haze – Guan Eng

By Ian McIntyre

Malaysia

Padang Rengas dispute exposes challenge facing possible BN-PN pact

You may be interested

Malaysia

MB’s resignation: “I was not informed” – Jalaluddin

Malaysia

Anwar rejects economic coercion, calls for fairer global trade order

Malaysia

Ismail Lasim resigns as Negeri Sembilan MB

Malaysia

Six ordered to attend court over second contempt proceedings in Negeri royal dispute

By Alfian Z.M. Tahir

Malaysia

Malaysia seeks greater defence self-reliance through expanded French military cooperation

Malaysia

Burnham says Brexit has left UK worse off as he seeks closer EU ties

Malaysia

Secretariat accuses Umno of undermining reconciliation with Negeri Sembilan Palace

By Alfian Z.M. Tahir

Malaysia

Malaysia - France poised to forge strategic partnership in defence, critical minerals